Health Care Service

Top Providers in the category

Hims

Hims is a publicly traded telehealth platform (NYSE: HIMS) offering weight loss plans that include both oral medication kits and compounded GLP-1 injections. Their program combines personalized medications with behavioral coaching, nutrition guidance, and provider check-ins through the Hims app.

Read More

Tuyo Health

Tuyo Health is a telehealth platform offering compounded and brand-name GLP-1 medications with insurance and cash-pay options. Founded by UCSF-trained Dr. German Echeverry, they provide personalized provider consultations, quarterly blood tests, and same-dose pricing across all treatment levels.

Read More

Read Latest Articles

Novo Nordisk Sues Lilly Over GLP-1 Ad Claims

Novo Nordisk has filed a lawsuit against Eli Lilly, claiming the company runs deceptive advertising for its GLP-1 medications. For patients comparing semaglutide and tirzepatide options, this legal battle raises real questions about how drug makers market weight loss treatments and what you should actually trust when making a medication decision.

Read More

Novo Nordisk Sues Eli Lilly Over GLP-1 Ads

Novo Nordisk has filed a lawsuit against Eli Lilly, alleging the company ran misleading advertising around its GLP-1 medications. For patients comparing semaglutide and tirzepatide options, here is what this legal fight actually means for your treatment decisions and costs.

Read More

Why Insurance Won't Cover Your GLP-1 Drug

Millions of Americans who qualify for GLP-1 medications like semaglutide and tirzepatide are being turned away by their insurance plans due to high drug costs. This article breaks down why coverage gaps exist, what it costs to pay out of pocket, and the real options available to help you afford treatment.

Read More

GLP-1 Retreats: What They Are and Do You Need One?

GLP-1 retreats are emerging as an immersive approach to weight loss that pairs medication with lifestyle coaching, behavioral therapy, and nutrition guidance. But are they necessary, or even accessible, for most people? Here's what you need to know before signing up or spending the money.

Read More

Generic Ozempic Approved in Canada: What It Means

Aspen Pharmacare has received Canadian approval to sell a generic version of semaglutide, the active ingredient in Ozempic, following Novo Nordisk's patent expiry in Canada. This marks a significant shift in the GLP-1 landscape that could eventually affect pricing and access across North America. Here is what patients and those considering GLP-1 therapy need to know.

Read More